Regulatory aspects of integration of pharmacogenetics into drug development

International Journal of Pharmaceutical Medicine

Volumn 15, Issue 2, 2001, Pages 67-69

  Shah, Rashmi R ^a  

^a Impact on Health Care and Health Economics Sub group   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450 2D6; DRUG; DRUG METABOLIZING ENZYME;

ARTICLE; DRUG APPROVAL; DRUG METABOLISM; DRUG SAFETY; DRUG SCREENING; DRUG TARGETING; DRUG TOLERABILITY; ENZYME METABOLISM; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; PHARMACOGENETICS; PHENOTYPE; PRIORITY JOURNAL;

EID: 0035020196     PISSN: 13649027     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124363-200104000-00007     Document Type: Article

References (5)

1. CPMP Guidance on 'Pharmacokinetic Studies in Man' (Eudra/C/87/013)